tbuckley/cabot-search huggingface dataset:
Variola: Reliability of Rapid Electron-Microscopic Diagnosis
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Aortic-vena caval fistula from ruptured aortic aneurysm
Authors: A. L. Colley
Journal: JAMA (1965)

THE SUDDEN rupture of an aortic aneurysm remains one of the most striking and urgent problems encountered in medicine. Free rupture, or rupture into another organ, may present a wide variety of symptoms, but common to most is evidence of blood loss. The subject of this report is observations on a patient with acute rupture of an abdominal aortic aneurysm into the inferior vena cava and retroperitoneal space. Reports of successful repairs of aortic-vena caval fistula from ruptured arteriosclerotic aneurysms have been appearing over the past 12 years.<sup>1-3</sup>The first successful repair of this lesion was reported by Cooley in 1955.<sup>4</sup>The Baylor group<sup>5</sup>in 1962 reported 1,400 patients treated for abdominal aortic aneurysms in a ten-year period. Of this group, 130 had ruptured and four of these had ruptured into the inferior vena cava. With development of this fistula, a rather typical pattern appears. In the
A piece of my mind. Requiem for an unknown leper
Authors: R. Crawshaw
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
From the NIH: Committee formulates definition and criterions of Guillain-Barre syndrome to aid in diagnosis
Journal: JAMA (1978)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Utilizing percentage of sarcomatoid differentiation as a prognostic factor in renal cell carcinoma.
Authors: Timothy Kim, Hui-Yi Lin, Binglin Yue, Jasreman Dhillon, Mayer N. Fishman, Einar Freyr Sverrisson, Philippe E. Spiess, Shilpa Gupta, Julio M. Pow-Sang, Michael Adam Poch, Wade Jeffers Sexton
Journal: Journal of Clinical Oncology (2014)

507 Background: Sarcomatoid renal cell carcinoma (sRCC) is a histologic feature that denotes an aggressive variant of kidney cancer and worse overall outcomes. Our aim was to determine if the percentage of sarcomatoid differentiation (% Sarc) could be used for prognostic risk stratification. Methods: We performed a retrospective analysis of patients who underwent surgery at our center and found to have sRCC. A single genitourinary pathologist reviewed each specimen for %Sarc and other pathologic variables of interest. %Sarc was analyzed as a continuous variable and as a binary variable using cut-points of 5%, 10%, and 25%. Potential prognostic factors associated with overall survival (OS) were determined using the Cox regression model. OS curves were generated with Kaplan-Meier methods and survival differences compared using the log-rank test. Results: Between 1998 and 2012, 1,307 consecutive cases of RCC were identified, of which 59 patients were confirmed to have sRCC (4.5%). As a continuous variable %Sarc was associated with OS (p=0.023). Predictors of survival on multivariable analysis included pT stage, tumor size, cM stage and % Sarc at the 25% binary level. OS was most dependent on the presence or absence of metastatic disease (4 months vs. 21.2 months, p=0.001). However, in a subgroup analysis of cM0 patients with locally advanced (≥ pT3) tumors, OS was significantly diminished in patients with &gt;25% Sarc compared to ≤25% Sarc (p=0.045). OS relative to %Sarc was no different in subgroup analyses of patients with early stage disease (pT1-T2, M0) or in patients with clinical metastatic disease. Conclusions: Patients with sRCC have a poor overall outcome as evidenced by high rates of recurrence and death. Patients without clinical metastatic disease and &gt;25% Sarc have a higher risk of relapse and worse OS. More effective understanding of the biological basis for the aggressive behavior of sarcomatoid RCC is needed, and nomograms to predict recurrence or survival following nephrectomy could incorporate this pathologic feature for added risk stratification.
Erratum
Journal: BMJ (1892)

Wimpole Street, W.) writes: I would advise It.B. to try pilocarpine (gr1I ) subcutaneously three times a day.In a case of hiccough which I recently saw with Mr. A. W. Harrison, I suggested pilocarpine, as other remedies had failed.The hiccough, which had been constant for a fortnight, at once lessened, and soon ceased entirely.
HAVE WE TOO MANY DOCTORS?
Journal: JAMA (1995)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The British Medical Journal
Journal: BMJ (1883)

URETHRAL SYRINGE.MIR. BALMANNO SQUIRE has forwarded us specimens of a very coIn- venient anid portable urethral syringe.The body of the syringe is a small flattened india-rubber sack with flat sides, connected with a glass nozzle, provided with an india-rubber cap.This syringe is very convenient, portable, and clean, and is, we judge, likely to answer its purlpose efficiently.It has the advantage of being cheap.The makers are Messrs.J. C. Ingram and Co. MITCHELL AND 'MUIL'S CHARCOAL BISCUITS.THESE biscuits, made by Messrs. Mitchell and Muil, of Aberdeen, will be found useful in flatulence, pyrosis, and other forms of dyspepsia.They are palatable, and free from grittiness.They may be eaten either alone or with butter.ing, in the 10,000 cases examined, either more or fewer instances of death from them than was to be expected.The committee are evidently alive to this, however, since we find them saying that too Rio Grande Valley.
HUMORAL FACTORS IN THE CONTROL OF HYPERTENSION
Authors: P. C.
Journal: Annals of Internal Medicine (1941)

Editorial1 February 1941HUMORAL FACTORS IN THE CONTROL OF HYPERTENSIONP. C.P. C.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-14-8-1449 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe demonstration by Goldblatt and his associates that injury to renal tissue produced by ischemia may result in sustained hypertension has stimulated a search for some substance to explain this activity. Some of the implications of Goldblatt's work have been discussed editorially in this journal.1It has been shown that the pressor response is not dependent upon the nervous system. The endocrine glands apparently play only a subsidiary part. Removal of the damaged kidney, however, abolishes the hypertension if the other kidney is normal. These facts led Goldblatt to suggest that the hypertension was excited by some substance that was...1 ANN. INT. MED., 1938, xii, 267-268. Google Scholar2 TIGERSTEDTBERGMANN RPG: Niere und Kreislauf, Skand. Arch. Physiol., 1898, viii, 223-271. CrossrefGoogle Scholar3 PAGE IH: On the nature of the pressor action of renin, Jr. Exper. Med., 1939, lxx, 521-542. CrossrefGoogle Scholar4 KOHLSTAEDTHELMERPAGE KGOMIH: Activation of renin by blood colloids, Proc. Soc. Exper. Biol. and Med., 1938, xxxix, 214-215. CrossrefGoogle Scholar5 PAGEHELMER IHOM: A crystalline pressor substance (angiotonin) resulting from the reaction between renin and renin-activator, Jr. Exper. Med., 1940, lxxi, 29-42. CrossrefGoogle Scholar6 GROLLMANWILLIAMSHARRISON AJRTR: The preparation of renal extracts capable of reducing the blood pressure of animals with experimental renal hypertension, Jr. Biol. Chem., 1940, cxxxiv, 115-121. CrossrefGoogle Scholar7 PAGE IH: Reduction of arterial blood pressure of hypertensive patients and animals with extracts of kidneys, Jr. Exper. Med., 1941, lxxiii, 7-41. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 February 1941Volume 14, Issue 8Page: 1449-1451KeywordsEndocrine physiologyHypertensionIschemiaKidneysNervous system ePublished: 1 December 2008 Issue Published: 1 February 1941 PDF downloadLoading ...
Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer.
Authors: I. Zighelboim, J. D. Wright, M. A. Powell, A. S. Case, E. L. Eisenhauer, D. E. Cohn, F. A. Valea, A. A. Secord, L. T. Lippmann, J. S. Rader
Journal: Journal of Clinical Oncology (2010)

TPS252 Background: The prognosis associated with cervical cancer that persists or recurs after treatment is exceedingly poor. These patients have traditionally been treated with systemic cytotoxic chemotherapy. A phase III trial conducted by the Gynecologic Oncology Group (GOG-179) demonstrated for the first time a survival benefit in patients treated with the dual-agent combination cisplatin and topotecan. The role of angiogenesis in cervical carcinogenesis, progression, and outcomes has been well documented. This effect is in part driven by HIF-1α and VEGF as one of its downstream effectors. Preliminary studies using bevacizumab in women with recurrent cervical cancer have shown encouraging results. We sought to determine the antitumor activity and safety of the combination of topotecan, cisplatin, and bevacizumab in patients with recurrent or persistent carcinoma of the cervix. Methods: Patients with histologically proven measurable and newly diagnosed first recurrence or persistent cervical carcinoma not amenable to curative intent treatments are deemed eligible for this single-arm phase II trial. Patients may have received only platinum in combination with radiation as part of their up-front treatment. Cisplatin 50 mg/m2 day 1 plus topotecan 0.75 mg/m2 days 1, 2, and 3 and bevacizumab 15 mg/kg day 1 are prescribed in a 21-day cycle. Cytokine support is allowed at physician discretion. The primary endpoint of this study is the probability of surviving progression free (PFS) for at least 6 months. Additionally, the frequency of clinical response and toxicity associated with this regimen will be assessed. Correlative studies include gene expression profiling and theranostic evaluation of 18F-fluorodeoxyglucose PET as an early indicator of response to therapy. Accrual goal (27 subjects) was established based on a 50% improvement in 6-month PFS in relation to GOG-179 (40% to 60%), with a one-sided 0.10 significance and 80% power. At the time of abstract submission a total of 14 subjects have been enrolled in three NCI-designated comprehensive cancer centers. Author Disclosure Employment or Leadership Position Consultant or Advisory Role Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration GlaxoSmithKline Genentech, GlaxoSmithKline
Exogenous sex hormone exposure and the risk for major malformations
Authors: E. J. Lammer
Journal: JAMA (1986)

Several studies have suggested that maternal use of exogenous sex hormones during early pregnancy may be associated with various congenital malformations. We conducted a case-control study of first-trimester sex hormone exposure among mothers of 1,091 infants with Down syndrome or at least one of 11 major malformations. For each malformation category, the infants with other malformations served as the control group. Associations were found between esophageal atresia and (1) any sex hormone exposure (odds ratio, 2.84); (2) progestins (odds ratio, 2.87); (3) nonspecified sex hormones (odds ratio, 2.99); and (4) hormonal pregnancy tests (odds ratio, 2.81). We found no potentially confounding variables for these associations. We found no statistically significant association between any malformation category and oral contraceptive exposure. Even if the relationship between esophageal atresia and noncontraceptive sex hormone exposure is causal, the absolute risk would be low, on the order of six per 10,000 exposed live births. (<i>JAMA</i>1986;255:3128-3132)
A Contortionist and His Medical Purchasers.
Journal: JAMA (2002)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
GEORGE R. MINOT (1885-1950) INQUIRING PHYSICIAN
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Microscope
Journal: JAMA (1942)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A Text Book of Morbid Histology for Students and Practitioners.
Journal: JAMA (1892)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE SCIENCE OF NUTRITION AND THE ARMY
Journal: JAMA (1918)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death—Reply
Authors: Dean Fergusson
Journal: JAMA (2008)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal